(Total Views: 619)
Posted On: 08/05/2020 2:20:53 AM
Post# of 149056
Re: nmbr1stckpckr #47157
I would find it very difficult to forgo Leronlimab, knowing what I know. Leronlimab may be a very unusual, if not singular drug in the history of medicine (I'm sure someone will make me regret the hyperbole at some point. Hopefully it will prove true).
The history of medicine is full of drugs that appeared effective, but ended up not being effective or came with dangerous or deadly side effects.
If you were a physician facing a pandemic and there were 10, 100 or 1000 drugs that all were represented as just what was needed to effect a cure, how would you proceed?
The FDA arose because dangerous food and medications. In spite of the huge toll of covid, the reality is that the fatality rate is at worst 3% and likely much less due to likely huge number of undiagnosed, minimally or asymptomatic patients.
All reasonable efforts should be made to accelerate the process of discovery, validation and approval (thus WARP speed program). What if Leronlimab did not exist, would you want a poorly vetted therapeutic or vaccine thrust upon you. I would not.
We need to act urgently, but not recklessly.
The history of medicine is full of drugs that appeared effective, but ended up not being effective or came with dangerous or deadly side effects.
If you were a physician facing a pandemic and there were 10, 100 or 1000 drugs that all were represented as just what was needed to effect a cure, how would you proceed?
The FDA arose because dangerous food and medications. In spite of the huge toll of covid, the reality is that the fatality rate is at worst 3% and likely much less due to likely huge number of undiagnosed, minimally or asymptomatic patients.
All reasonable efforts should be made to accelerate the process of discovery, validation and approval (thus WARP speed program). What if Leronlimab did not exist, would you want a poorly vetted therapeutic or vaccine thrust upon you. I would not.
We need to act urgently, but not recklessly.
(2)
(0)
Scroll down for more posts ▼